Market News & Trends
Catalent Announces Agreement Center for iPS Cell Research & Application
Catalent Pharma Solutions recently announced an agreement with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to make a…
Curie-Cancer & DNA Therapeutics Partner in Fight Against Cancers
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and DNA Therapeutics recently announced they are renewing their partnership. The ongoing collaboration will…
Harlan Contract Research Services & Bertin Pharma Sign Strategic Collaboration
Harlan Contract Research Services and Bertin Pharma recently announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the…
Cobra Biologics & BioCancell Announce Agreement for Promising Cancer Therapy
Cobra Biologics and BioCancell recently announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials. BioCancell’s Phase I clinical trial for BC-821, scheduled…
Boom in Smart Pills Will Reach a New Peak by 2018-2020
The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and…
Corium International Files for IPO
Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture, and commercialization of specialty transdermal pharmaceutical products, recently announced it has filed a…
Abingworth Raises $375 Million for Life Sciences Fund
Abingworth, the international investment group dedicated to life sciences and healthcare, recently announced the final closing of its $375-million fund, Abingworth Bioventures VI (ABV VI).…
Northwest Biotherapeutics Aims to Dominate Brain Cancer
Ten years ago, cash-strapped biotechnology company Northwest Biotherapeutics Inc. was down to three employees and 1 week from closing its doors when a financial backer…
Tekmira Presents Recent Advances in mRNA Delivery
Tekmira Pharmaceuticals Corporation recently announced that recent advances in the enablement of messenger RNA (mRNA) using Tekmira's lipid nanoparticle (LNP) technology were presented by Tekmira's…
Croda Celebrates EXCiPACT Double
Croda recently announced it is celebrating two achievements in relation to EXCiPACT, the voluntary scheme that reduces the audit burden in the pharmaceutical industry by…
West Receives CE Mark for Intradermal Adapter for Disposable Syringes
West Pharmaceutical Services, Inc, a leading global developer and manufacturer of components and systems for injectable drug delivery, received CE approval of its Intradermal (ID)…
Thesan Pharmaceuticals Announces $49-Million Financing
Thesan Pharmaceuticals recently announced the closing of a $49-million Series B financing, led by Novo Ventures, with SV Life Sciences and Lundbeckfond Ventures joining Novartis…
Global Genomics Group & Quintiles to Collaborate
Global Genomics Group (G3) and Quintiles recently announced they will collaborate to investigate novel biomarkers and biological pathways for use in the development of diagnostic…
Metrics, Inc. Expands With Fast-Track Product Development Laboratory
Metrics Inc. is making significant investments in its facilities and equipment for the benefit of contract services clients by opening a new laboratory to better…
Nuvilex Announces $27-Million Funding to Advance Late-Phase Clinical Trials
Nuvilex, Inc. recently announced it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor. Lincoln Park initially…
Nuevolution Announces Exclusive License Agreement
Nuevolution A/S recently announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the…
Roche Signs Licensing Agreement with Sysmex Inostics GmbH
Roche recently announced a licensing agreement with Sysmex Inostics GmbH for its emPCR portfolio of patents. Under the terms of the licensing agreement, Roche grants…
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million…
Actavis to Buy Forest for $25 Billion
Generic drugmaker Actavis Plc said on Tuesday it would buy Forest Laboratories Inc. for about $25 billion in cash and stock, expanding its portfolio of…
Zosano Strikes $115-Million+ Plus Deal
Zosano Pharma, Inc. recently announced it has entered into an agreement with Novo Nordisk to develop a new transdermal presentation of semaglutide, an investigational proprietary…
